Endogenous hormones, such as insulin-like growth factor-I (IGF-I) and free testosterone (unbound testosterone that is biologically active), have been associated with a higher risk of metabolic syndrome, cardiovascular disease, and some obesity-related cancers [8–12] and may play a role in these associations. Here, IGF1 is linked to metabolic syndrome.